Haytaian Peter D has filed 24 insider transactions across 1 company since March 2023.
Most recent transaction: a tax payment of 446 shares of Elevance Health, Inc. ($ELV) on March 03, 2026.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 446 | $284.03 | 27,222.0000 | 224,600,000 | 1.61% | 0.00% |
| March 2, 2026 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 2865 | $0.00 | 27,668.0000 | 224,600,000 | 11.55% | 0.00% |
| March 2, 2026 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 1201 | $294.07 | 24,803.0000 | 224,600,000 | 4.62% | 0.00% |
| March 3, 2025 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Employee Stock Option (Right to Buy) | 11549 | $0.00 | 11,549.0000 | 232,900,000 | 9999.99% | 0.00% |
| March 3, 2025 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 2281 | $395.50 | 18,756.0000 | 232,900,000 | 10.84% | 0.00% |
| March 3, 2025 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 3035 | $0.00 | 21,791.0000 | 232,900,000 | 16.18% | 0.00% |
| March 3, 2025 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 4213 | $0.00 | 26,004.0000 | 232,900,000 | 19.33% | 0.00% |
| Nov. 1, 2024 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 1649 | $414.01 | 17,238.0000 | 233,600,000 | 8.73% | 0.00% |
| Nov. 1, 2024 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 3799 | $0.00 | 21,037.0000 | 233,600,000 | 22.04% | 0.00% |
| March 4, 2024 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | M | Common Stock | 15000 | $166.97 | 39,982.0000 | 237,400,000 | 60.04% | 0.01% |
| March 4, 2024 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | S | Common Stock | 4206 | $500.18 | 35,776.0000 | 237,400,000 | 10.52% | 0.00% |
| March 4, 2024 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | S | Common Stock | 1889 | $500.18 | 33,887.0000 | 237,400,000 | 5.28% | 0.00% |
| March 4, 2024 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | S | Common Stock | 15000 | $500.18 | 18,887.0000 | 237,400,000 | 44.26% | 0.01% |
| March 1, 2024 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Employee Stock Option (Right to Buy) | 9280 | $0.00 | 9,280.0000 | 237,400,000 | 9999.99% | 0.00% |
| March 4, 2024 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | M | Employee Stock Option (Right to Buy) | 15000 | $0.00 | 4,908.0000 | 237,400,000 | 75.35% | 0.01% |
| March 1, 2024 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 2405 | $0.00 | 15,830.0000 | 237,400,000 | 17.91% | 0.00% |
| March 1, 2024 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 9152 | $0.00 | 24,982.0000 | 237,400,000 | 57.81% | 0.00% |
| March 1, 2024 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 4314 | $499.11 | 13,425.0000 | 237,400,000 | 24.32% | 0.00% |
| Nov. 1, 2023 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 154 | $446.66 | 17,739.0000 | 242,800,000 | 0.86% | 0.00% |
| March 1, 2023 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 9716 | $0.00 | 23,362.0000 | 242,800,000 | 71.20% | 0.00% |
| March 2, 2023 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 5469 | $468.78 | 17,893.0000 | 242,800,000 | 23.41% | 0.00% |
| March 1, 2023 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Employee Stock Option (Right to Buy) | 8812 | $0.00 | 8,812.0000 | 242,800,000 | 9999.99% | 0.00% |
| March 1, 2023 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 607 | $469.03 | 11,354.0000 | 242,800,000 | 5.07% | 0.00% |
| March 1, 2023 | Elevance Health, Inc. | $ELV | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 2292 | $0.00 | 13,646.0000 | 242,800,000 | 20.19% | 0.00% |